Moolec Science SA Files 6-K with Financial Statements
Ticker: MLECW · Form: 6-K · Filed: Jan 31, 2025 · CIK: 1937737
Sentiment: neutral
Topics: financial-statements, 6-K, filing
TL;DR
Moolec Science SA dropped its latest financials in a 6-K filing, check the numbers.
AI Summary
Moolec Science SA filed a Form 6-K on January 31, 2025, incorporating unaudited interim condensed consolidated financial statements as of September 30, 2024, and June 30, 2024, for the three-month periods ended September 30, 2024, and 2023. This filing is also incorporated by reference into the company's registration statements on Form F-3 and Form S-8.
Why It Matters
This filing provides investors with updated financial information for Moolec Science SA, crucial for assessing the company's performance and making informed investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing (6-K) and does not contain new material events or significant financial changes.
Key Players & Entities
- Moolec Science SA (company) — Registrant
- 001-41586 (company) — SEC File Number
- 333-283113 (company) — Form F-3 Registration Number
- 333-282263 (company) — Form S-8 Registration Number
- September 30, 2024 (date) — Financial Statement Date
- June 30, 2024 (date) — Financial Statement Date
- September 30, 2024 (date) — Financial Period End
- September 30, 2023 (date) — Financial Period End
FAQ
What type of financial statements are included in this 6-K filing?
The filing includes unaudited interim condensed consolidated financial statements.
What are the dates for which financial statements are provided?
The financial statements are as of September 30, 2024, and June 30, 2024, and for the three-month periods ended September 30, 2024, and 2023.
What is the SEC file number for Moolec Science SA?
The SEC file number for Moolec Science SA is 001-41586.
Which registration statements does this 6-K filing incorporate by reference?
This 6-K filing is incorporated by reference into Moolec Science SA's registration statements on Form F-3 (Registration No. 333-283113) and Form S-8 (Registration No. 333-282263).
What is the principal executive office address of Moolec Science SA?
The principal executive office address is 17, Boulevard F. W. Raiffeisen, L-2411 Luxembourg, Grand Duchy of Luxembourg.
Filing Stats: 218 words · 1 min read · ~1 pages · Grade level 11.8 · Accepted 2025-01-31 16:05:34
Filing Documents
- ea0228128-6k_moolec.htm (6-K) — 10KB
- ea022812801ex99-1_moolec.htm (EX-99.1) — 333KB
- 0001213900-25-008835.txt ( ) — 344KB
From the Filing
OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of January 2025 Commission File Number: 001-41586 MOOLEC SCIENCE SA (Exact name of Registrant as Specified in Its Charter) 17, Boulevard F. W. Raiffeisen L-2411 Luxembourg, Grand Duchy of Luxembourg (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F EXHIBIT LIST This Form 6-K is incorporated by reference into the Company’s registration statements on Form F-3 (Registration No. 333-283113) and Form S-8 (Registration No. 333-282263), and the following exhibit is filed as part of this Form 6-K: Exhibit No. Description 99.1 Moolec Science SA unaudited interim condensed consolidated financial statements as of September 30, 2024 and June 30, 2024, and for the three-month periods ended September 30, 2024 and 2023. 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MOOLEC SCIENCE SA (Registrant) Dated: January 31, 2025 By: /s/ Gastón Paladini Name: Gastón Paladini Title: Chief Executive Officer 2